Tag: Vaccines
Pfizer Seeks FDA Approval of COVID-19 Boosters for Children Ages 5 to 11
Initial two-dose series of the Pfizer vaccine was authorized for that age group in October
Antibiotic Use in Under 2s May Reduce Antibody Response to Vaccines
Possible negative association of history of antibiotic prescriptions with vaccine-induced immunity seen in young children
Myocarditis, Pericarditis Risk Highest After Second COVID-19 Vaccine Dose
In large cohort, there were 5.55 excess events per 100,000 vaccinees after BNT162b2 and 18.39 after mRNA-1273
Risk for Guillain-Barré Syndrome Up After Ad.26.COV2.S Vaccination
Adjusted rate ratio of 20.56 found in head-to-head comparison of Ad.26.COV2.S with mRNA COVID-19 vaccines
Vaccination Coverage in Kindergarteners Dropped in 2020 to 2021
3.9 percent of kindergarteners who did not have vaccine exemptions were not up to date for MMR in 2020 to 2021
No Increased Risk for Appendicitis Reported With mRNA COVID-19 Vaccination
Findings from nationwide study in Denmark show no increased risk in association with vaccination or SARS-CoV-2 infection
AACR: Novel COVID-19 Vaccine Aimed at Immunocompromised Patients
CoVac-1, a peptide vaccine, induces T-cell immune responses in those with B-cell deficiencies, particularly leukemia and lymphoma patients
Early Effectiveness Assessed for Fourth Dose of BNT162b2 Vaccine
Difference in absolute risk for three versus four doses was 180.1 and 68.8 cases per 100,000 for COVID-19-related hospitalization, severe COVID-19
Moderna Says Its Combo Vaccine Effective Against Omicron
Company says the combination vaccine triggers antibodies capable of fighting several variants, including beta and omicron
COVID-19 Response Coordinator Says Adults Older Than 60 Should Get Second Booster
The FDA authorized a second booster of the Pfizer and Moderna vaccines on March 29 for anyone 50 years and older